Metabolic psychiatry, a field focusing on the connection between metabolism and mental health, is emerging as a critical approach to treating psychiatric conditions by addressing underlying metabolic dysfunctions.
2
Insulin resistance, prevalent in a significant portion of the population, doubles the risk of depression and is a key driver of mental illness, affecting both brain structure and function.
3
Ketogenic diets and other metabolic interventions have shown profound positive effects in clinical trials for serious mental illnesses like schizophrenia and bipolar disorder, leading to reversals of metabolic syndrome and significant reductions in psychiatric symptoms.
4
The field is moving towards personalized psychiatry, utilizing advanced diagnostics like omic profiling (proteomics, metabolomics, epigenetics) and AI to understand individual metabolic dysfunctions and tailor treatments.
Protocols
Concrete recipes — what, when, how much, and why
4 items
Metabolism-Based Interventions for Psychiatric Conditions
WhatUtilizing dietary and lifestyle changes, and potentially specific medications, to address underlying metabolic dysfunctions that contribute to mental illness.
For whomPatients with bipolar disorder, schizophrenia, depression, anxiety, and eating disorders, especially those with co-occurring metabolic syndrome or insulin resistance.
WhyMany psychiatric conditions, including serious mental illnesses, are linked to metabolic issues like insulin resistance, inflammation, and mitochondrial dysfunction. Addressing these root causes can lead to significant improvements in mental health.
CaveatsRequires significant support for patients, especially those with severe mental illness, to implement and maintain lifestyle changes. Should be supervised by trained professionals.
The speaker's program at Stanford focuses on these interventions, recognizing that traditional psychiatric treatments often overlook the body's role. By addressing metabolic issues, such as through ketogenic diets, the aim is to reset the brain's energy system and improve overall brain function. This approach has shown promise in reversing metabolic syndrome and significantly reducing psychiatric symptoms, offering a more holistic and potentially more effective treatment path.
Mechanism
Targets shared pathogenic relationships between metabolic and psychiatric diseases by improving energy production, reducing inflammation and oxidative stress, and enhancing neuronal plasticity.
Personal experience
The speaker's interest in this area stemmed from observing the impact of nutrition and obesity on psychiatric symptoms in patients, particularly one with treatment-resistant schizophrenia. This led to exploring ketogenic therapies and adapting them for psychiatric conditions, eventually establishing a dedicated program at Stanford.
I started the a program at Stanford which is focused on metab metabolism based interventions for uh those with bipolar or schizophrenia or depression and also eating disorders.
Also said
“You see profound changes in these and treatable mental illnesses uh using this approach of metabolic psychiatry and nutrition and food.”— Highlights the significant impact of this approach on severe mental illnesses.
“Generally there's four mechanisms of metabolic disease. There's plasticity you mentioned the inflammation. Um there's oxidative stress and there's mitochondrial dysfunction.”— Outlines the key biological targets of metabolic interventions.
Ketogenic Diet for Serious Mental Illness
WhatImplementing a ketogenic diet, characterized by very low carbohydrate intake, moderate protein, and high fat, to induce a state of ketosis.
DoseA pilot study showed significant results within four months.
For whomPatients with serious mental illnesses like schizophrenia and bipolar disorder, as well as depression and potentially certain eating disorders (e.g., binge eating, bulimia).
WhyThe ketogenic diet can reset the brain's energy system, improve insulin sensitivity, reduce inflammation, and provide an alternative fuel source (ketones) for the brain, which can be beneficial when glucose metabolism is impaired.
CaveatsRequires significant support and monitoring, especially for patients with severe mental illness. It is a restrictive diet and should be medically supervised. Not suitable for all eating disorders (e.g., anorexia nervosa, where restriction is a core pathology).
A pilot study at Stanford demonstrated remarkable efficacy of the ketogenic diet in patients with bipolar disorder and schizophrenia. Within four months, 100% of participants reversed metabolic syndrome, experienced significant weight loss (12%), reduction in belly fat (36%), and improved insulin resistance (27%). Crucially, psychiatric symptoms dramatically decreased, alongside improvements in sleep and life satisfaction. The speaker notes that these are 'good side effects' compared to conventional psychiatric drugs. While challenging to implement, especially for mentally ill patients, support groups and framing it as a 'metabolic therapy' rather than just a diet help with adherence. The long-term adherence observed in the study suggests its feasibility.
Mechanism
By shifting the body's primary fuel source from glucose to ketones, the ketogenic diet can bypass impaired glucose metabolism in the brain (cerebral glucose hypometabolism). Ketones provide a more efficient and cleaner fuel, reduce oxidative stress, and have anti-inflammatory properties. It also improves insulin sensitivity and can reverse metabolic syndrome.
Personal experience
The speaker's work with ketogenic therapies for seizures led to adapting them for psychiatric conditions. The positive outcomes in clinical trials, and the continued adherence of patients years later, are personally encouraging.
In your clinical trial, you did on the ketogenic diet for bipolar schizophrenia that recently published uh with 23 patients. You had 100% reversal of the metabolic syndrome or pre-diabetes.
Also said
“It does encourage people um to stick with it more and I think you know over time also organically the more uh mutual patients with other clinicians in cardiology, endocrinology or primary care see their patients improving with reduction in visceral fat and improvement of you know other metabolic markers aside from the psychiatric markers and people start to uh appreciate it and are grateful that their patients are doing better and the patients themselves also themselves almost feel like they have more control over their life.”— Explains how positive outcomes motivate patients and other clinicians to embrace the therapy.
“To me it's not it's not a diet. it's actually the way we should we should be eating more like this. Is that changing neurocognition? Is that changing the obsessions or compulsions for example that you sometimes do see in anorexia and the rigidity?”— Reframes the ketogenic diet as a fundamental way of eating rather than a temporary diet, and questions its potential impact on cognitive aspects of eating disorders.
Optimizing Nutrient Levels and Addressing Deficiencies
WhatRoutinely testing and optimizing levels of essential nutrients, vitamins, and co-factors that are critical for metabolic and brain function.
WhenAs part of initial assessment and ongoing monitoring for psychiatric patients.
DoseIndividualized based on test results.
For whomAll psychiatric patients, especially those with serious mental illness, metabolic syndrome, or insulin resistance.
WhyMany psychiatric patients are malnourished or deficient in key nutrients required for optimal mitochondrial function, neurotransmitter synthesis, and overall metabolic health. Addressing these deficiencies is a fundamental step in treatment.
CaveatsRequires comprehensive testing beyond standard panels. Optimization should be guided by clinical expertise.
The speaker emphasizes that it's a 'crime' not to consider nutrient deficiencies in psychiatric care, especially given that a vast majority of the population has some metabolic abnormality and is often 'overfed and undernourished.' In their clinic, they routinely test for and optimize vitamins, co-factors, and other essential nutrients. The argument is that treating psychiatric symptoms solely with medication while ignoring underlying malnutrition or metabolic issues is incomplete. The body requires a full spectrum of ingredients for optimal function, and a reductionist approach focusing on one supplement is insufficient; a holistic view of all factors is necessary.
Mechanism
Nutrients like B vitamins, CoQ10, omega-3s, vitamin D, magnesium, zinc, and iron act as co-factors or direct components in metabolic pathways, energy production (TCA cycle), and neurotransmitter synthesis. Deficiencies impair these processes, contributing to brain dysfunction and psychiatric symptoms. Supplementation aims to restore optimal function.
So we test for that in our clinic. We test for um all of these things and we optimize. Um so we we have a approach that we use to make sure that people are not deficient in these in these things because if someone's deficient, does that make sense to treat them only with medication and ignore the fact that they're deficient or malnourished in some way.
Also said
“It's almost like a crime to not to not uh be thinking about it.”— Highlights the speaker's strong conviction about the importance of this approach.
“If your omega-3 is low and you take it, great. But if your vitamin D and magnesium are also low might not work as well, right?”— Illustrates the need for a holistic approach rather than single-nutrient focus.
Monitoring Biomarkers of Mental Illness
WhatRoutinely checking a comprehensive panel of metabolic and nutritional biomarkers to identify underlying dysfunctions contributing to mental illness.
WhenAs part of initial diagnostic workup and ongoing treatment monitoring.
For whomAll individuals with mental health concerns, from anxiety and depression to serious mental illnesses like schizophrenia and bipolar disorder.
WhyMental illness is heterogeneous and often stems from various underlying biological dysfunctions. Biomarkers provide objective data to identify these root causes, allowing for personalized and targeted interventions beyond symptom-based diagnoses.
CaveatsRequires advanced lab testing beyond typical clinical panels. Interpretation requires expertise in metabolic and functional medicine.
The speaker advocates for a shift from symptom-based psychiatric diagnoses (like the DSM-5) to a biomarker-driven approach. They emphasize that there isn't one single biomarker for mental illness, but rather a group of markers that, when assessed together, can reveal specific metabolic disease states and their progression. For example, the triglyceride/HDL ratio is a strong indicator of insulin resistance and has been linked to both the severity and chronicity of depression. Other crucial markers include insulin measurements, inflammation markers (CRP), and a wide array of nutrient levels. This comprehensive testing allows for a personalized understanding of an individual's unique dysfunctions, enabling more effective, targeted treatments.
Mechanism
Biomarkers like triglyceride/HDL ratio, fasting insulin, C-reactive protein (CRP), omega-3 index, vitamin D, homocysteine, methylmalonic acid, thyroid hormones, sex hormones, iron, and zinc levels provide insights into insulin resistance, inflammation, mitochondrial function, nutrient deficiencies, and hormonal imbalances. These are all interconnected pathways that influence brain health and psychiatric symptoms.
You have to find everything that's off and fix it. In other words, if your omega-3 is low and you take it, great. But if your vitamin D and magnesium are also low might not work as well, right?
Also said
“I mean I when I think about it it's you want to check your nutrient levels that affect mental health like vitamin D and homocyine and methylic acid and omega-3 fats and omega-3 index and hormonal effects like thyroid and sex hormones and your iron levels and zinc levels and insulin insulin measurements and some resistance scores.”— Lists a comprehensive set of specific biomarkers to be monitored.
“What was interesting about that study is that insulin sensitivity wasn't associated with the chronicity of depression but it was for the severity but the triglyceride HDL ratio was associated with both.”— Provides a specific example of a nuanced biomarker finding.
What's new
Personal practice updates, fresh positions, predictions
7 items
Metabolic Psychiatry as a Holistic Field
0:04:40
Metabolic psychiatry is defined as the study of the connection between metabolism and mental health, encompassing both systemic and central metabolic dysfunctions and their impact on psychiatric disease.
Why this matters: This definition broadens the scope beyond just brain energy metabolism or ketogenic diets, emphasizing a comprehensive approach to mental health rooted in metabolic health.
Background
Historically, psychiatry has often neglected the body's influence on the brain, focusing primarily on neurotransmitters. The concept of metabolic psychiatry reintroduces a holistic view, acknowledging that metabolic issues like insulin resistance, inflammation, and mitochondrial dysfunction are fundamental to mental illness.
The speaker clarifies that metabolic psychiatry is not limited to brain energy metabolism or the ketogenic diet but is a broader, more holistic term. It investigates how metabolic dysfunctions, both within the brain (central) and throughout the body (systemic), affect psychiatric symptoms, disease progression, and treatment. This approach recognizes that the body and brain are interconnected, and issues in one can profoundly impact the other. The goal is to understand these connections for prevention, progression, and treatment of psychiatric conditions.
Metabolic psychiatry is thinking about that metabolism and mental health connection. But it's the study of all of the metabolic dysfunctions both systemic as well as central.
Also said
“I want to clear that up because metabolic psychiatry really is a more holistic term that incorporates all systemic as well as central metabolic dysfunction and how that affects psychiatric disease.”— Reinforces the comprehensive nature of the field.
Insulin Resistance and Mental Illness Risk
0:08:00
Insulin resistance, affecting one in three Americans, doubles the risk of developing depression, even in individuals with no prior psychiatric history.
Why this matters: This highlights a direct and significant biological link between a common metabolic condition and mental health, suggesting a widespread, under-recognized root cause for depression.
Background
The host notes that 93.2% of Americans have some form of metabolic dysfunction, including high blood sugar, high blood pressure, abnormal cholesterol, or being overweight/obese, all linked to insulin resistance. This widespread metabolic issue is driven by modern diets high in sugar and starch.
The speaker emphasizes the profound impact of insulin resistance on mental health, stating that one in three people in the US have insulin resistance, which doubles their risk of depression, even without a history of psychiatric issues. This connection is often overlooked, as people typically associate poor diet with weight gain but not with mental health. The host further elaborates that if one includes all forms of metabolic dysfunction (high blood sugar, blood pressure, abnormal cholesterol, overweight/obesity), the prevalence in Americans rises to 93.2%, indicating a massive public health crisis with direct implications for mental well-being. This metabolic dysfunction creates a vicious cycle where depression can worsen self-care, further exacerbating metabolic issues.
One in three people have insulin resistance in the United States and that doubles your risk of developing depression even if you have had no psychiatric history.
Also said
“If you combine all those which are all related to the fundamental biology of insulin resistance which I want to unpack with you that's 93.2% of Americans.”— Quantifies the widespread nature of metabolic dysfunction in the US.
“People don't understand that, yeah, okay, I guess if I eat too many cookies or have too much soda, I'll gain weight and I'll get overweight. But they don't connect the dots with mental health.”— Highlights the public's lack of awareness regarding the mental health impact of diet.
Cerebral Glucose Hypometabolism and Brain Insulin Resistance
0:10:00
Certain areas of the brain in psychiatric conditions like schizophrenia, bipolar disorder, and neurodegenerative diseases cannot effectively use glucose for energy, a phenomenon known as cerebral glucose hypometabolism, which is often linked to central insulin resistance.
Why this matters: This explains a core biological mechanism behind brain dysfunction in mental illness, showing that the brain can be 'starved' of energy even when glucose is present, and that this can occur independently of peripheral insulin resistance.
Background
The speaker notes that this central insulin resistance and impaired glucose signaling in the brain can be observed even before a diagnosis of psychosis or the administration of psychiatric medications, suggesting it's a primary driver rather than a side effect.
Cerebral glucose hypometabolism, where specific brain regions struggle to utilize glucose for energy despite its presence, is a central pathological feature in neurodegenerative conditions, schizophrenia, and bipolar disorder. This is often accompanied by central insulin resistance, meaning insulin signaling and glucose processing within the brain are impaired. Crucially, this brain-specific insulin resistance can exist independently of peripheral (body-wide) insulin resistance and has been observed even before the onset of psychosis or medication use. This suggests a direct link between impaired brain energy metabolism and the development of psychiatric illness. Insulin signaling is vital for neuronal plasticity, growth, and remodeling, so its disruption has significant consequences for brain health.
So cerebral glucose hypom metabolism um in the brain globally is a central pathological characteristic of neurodeenerative conditions and uh also present in uh schizophrenia and bipolar in particular.
Also said
“When you have insulin resistance in the brain, that doesn't necessarily mean that you'll have insulin resistance in the body.”— Clarifies that central and peripheral insulin resistance can be distinct.
“It's really important because it's important for neuronal plasticity uh neuron uh neuronal growth remodeling shaping. It's extreme insulin signaling is critical for that.”— Explains why insulin signaling in the brain is critical for brain function.
Mitochondrial Dysfunction in Mental Illness
0:13:00
Mitochondrial dysfunction, where the 'energy factories' within cells operate at reduced capacity, is a common feature across a spectrum of brain dysfunctions, including autism, ADD, Alzheimer's, Parkinson's, depression, bipolar disorder, and schizophrenia.
Why this matters: This highlights a shared underlying biological pathway for a wide range of seemingly disparate neurological and psychiatric conditions, suggesting common therapeutic targets.
Background
The brain, despite being only 2% of body weight, consumes 20% of the body's energy, making it highly vulnerable to deficits in energy production. Type 2 diabetics, for instance, have mitochondria functioning at half the rate of healthy individuals.
Mitochondrial dysfunction is identified as a central feature in a broad spectrum of brain disorders, from autism and ADD to neurodegenerative diseases like Alzheimer's and Parkinson's, and psychiatric conditions such as depression, bipolar disorder, and schizophrenia. The brain is particularly susceptible to energy deficits because it is highly metabolically active, consuming a disproportionate amount of the body's energy. When mitochondria, the cellular powerhouses, don't function optimally (as seen in insulin resistance or type 2 diabetes), it leads to increased oxidative stress and inflammation, creating a vicious cycle of dysfunction. The speaker suggests that interventions targeting these mitochondrial issues can create a 'virtuous cycle' of improvement.
So mitochondria essentially the little energy factories inside your cells and there's anywhere from hundreds to thousands and tens of thousands in the brain. It's the most dense per brain cell is the most mitochondria of any cell in your body.
Also said
“What we find is if you're a type two diabetic or if you have insulin resistance, your mitochondria don't work as well and that creates a whole downstream set of consequences.”— Connects insulin resistance directly to mitochondrial dysfunction.
“It's all this spectrum of brain dysfunction and and the there's a lot of common pathways involved in all these.”— Emphasizes the shared biological basis across various brain disorders.
Metformin as a Metabolic Intervention for Psychiatric Symptoms
0:15:40
Metformin, a drug known for improving insulin sensitivity, also crosses the blood-brain barrier, offering neuroprotective effects, supporting mitochondrial function, and reducing inflammation, thereby potentially improving psychiatric symptoms, especially in treatment-resistant bipolar depression.
Why this matters: This illustrates how a drug traditionally used for metabolic conditions can have direct benefits for mental health by targeting shared metabolic pathways, suggesting a broader application for existing medications.
Background
The speaker notes that traditional psychiatric approaches often focus on neurotransmitters, but the underlying metabolic dysfunctions are often overlooked. Metformin represents a 'tool in the toolbox' that addresses these deeper issues.
Metformin, commonly used to improve glucose metabolism and insulin sensitivity, is highlighted as a metabolic intervention with psychiatric benefits. It crosses the blood-brain barrier, providing neuroprotective effects and supporting the TCA cycle within mitochondria, which is crucial for energy production. Beyond its glucose-lowering effects, metformin also reduces inflammation by decreasing markers like TNF-alpha and interleukin-6, which are known to affect serotonin synthesis and tryptophan metabolism. A study on treatment-resistant bipolar depression showed that metformin, when used adjunctively with psychiatric medication, improved outcomes, suggesting it helps existing medications work more effectively by addressing underlying metabolic issues.
For example, you could take metformin. A lot of us know, right? Metformin improves glucose. uh yeah it improves insulin sensitivity but it also crosses the bloodb brain barrier and it has a neuroprotective effect.
Also said
“It also does decrease inflammation. So in some studies it's been shown to reduce TNF alalfa reduce interlucan 6 reduce other cytoines.”— Details metformin's anti-inflammatory actions.
“It allowed the psychiatric medication on board to work better.”— Shows metformin's role in enhancing the efficacy of conventional psychiatric treatments.
Ketogenic Diet for Serious Mental Illness
0:25:00
A clinical trial demonstrated that a ketogenic diet led to 100% reversal of metabolic syndrome, significant reductions in body weight, belly fat, and insulin resistance, and dramatic improvements in psychiatric symptoms, sleep, and life satisfaction in patients with bipolar disorder and schizophrenia within four months.
Why this matters: This provides strong evidence for a dietary intervention as a powerful therapeutic tool for severe mental illnesses, offering 'good side effects' compared to conventional drug treatments.
Background
The speaker's program at Stanford focuses on metabolism-based interventions for bipolar disorder, schizophrenia, depression, and eating disorders, stemming from observations of metabolic issues in psychiatric patients and the efficacy of ketogenic therapies for seizures.
The speaker highlights a pilot study on the ketogenic diet for bipolar disorder and schizophrenia, which yielded remarkable results in just four months. All 23 patients experienced a 100% reversal of metabolic syndrome or pre-diabetes. Additionally, there was a 12% reduction in body weight, a 36% reduction in belly fat, and a 27% reduction in insulin resistance. Beyond these metabolic improvements, patients showed dramatic reductions in psychiatric symptoms, improved sleep, and increased life satisfaction. This contrasts sharply with conventional psychiatric medications, which often come with negative side effects, whereas the ketogenic diet offered numerous 'good side effects.' The feasibility of adherence was also noted, with many patients from the pilot study continuing the diet years later.
Personal experience
The speaker's journey into this area began with exposure to nutrition in medical school and an interest in obesity medicine. This led to learning about ketogenic therapies for seizures and adapting them for psychiatric conditions, eventually leading to research trials and the establishment of a program at Stanford focused on metabolism-based interventions for serious mental illnesses and eating disorders. The speaker emphasizes the personal satisfaction of seeing patients improve with these tools.
You had 100% reversal of the metabolic syndrome or pre-diabetes. You had 12% reduction in body weight. You had a 36% reduction in belly fat, 27% reduction in insulin resistance, which by the way, the homir is probably not as good as the uh this new insulin resistance score that Quest is doing through the mass aspect.
Also said
“And when you take a drug for schizophrenia, all the side effects are bad, right? Here. all the side effects are good.”— Contrasts the positive side effects of the ketogenic diet with negative drug side effects.
“A lot of them are still on a ketogenic diet. So, it does speak to I guess the feasibility of being on it um over time.”— Addresses the common concern about long-term adherence to restrictive diets.
Personalized Psychiatry and Advanced Diagnostics
0:36:00
The future of metabolic psychiatry involves combining metabolic insights with personalized approaches, utilizing advanced 'omics' profiling (proteomics, metabolomics, epigenetics) and AI/machine learning to create targeted treatments based on individual metabolic dysfunctions.
Why this matters: This represents a paradigm shift from symptom-based diagnosis to root-cause, precision medicine in psychiatry, moving beyond a 'one-size-fits-all' approach.
Background
Traditional psychiatry often relies on symptom-based diagnoses (like the DSM-5) which categorize illness without explaining underlying causes. The speaker advocates for moving towards understanding the 'why' behind symptoms.
The speaker emphasizes the need to move beyond reductionist, symptom-based approaches in psychiatry towards personalized, precision medicine. This involves combining metabolic psychiatry with individual-specific data. The ongoing randomized controlled trial at Stanford is collecting a vast array of 'omics' data, including proteomics (blood proteins), metabolomics (blood metabolites), epigenetics (DNA methylation and gene expression), and wearable data (HRV, continuous glucose, and ketone monitoring). This rich dataset, combined with AI and machine learning, aims to identify specific metabolic dysfunctions for each patient, allowing for highly targeted interventions. The goal is to understand who will respond best to which treatment, moving away from generalized approaches.
So, we sort of combine met metabolic psychiatry with personalized psychiatry. it becomes are much more effective, more precision. Yeah.
Also said
“We can look at the microbiome. We can look at the mitochondria. We can look at, you know, the gut and and food sensitivities. We can look at nutritional status in different people. We look at toxin load in different people. We can look at all these different things that play a role.”— Illustrates the multi-faceted approach of personalized functional medicine.
“We're poised at a very good time right now to be able to use technology to really understand you know the science and the mechanisms and it's not just the sky. There's a whole universe now, right?”— Expresses optimism about the current technological capabilities for deep biological understanding.
Recommendations
Products, supplements, and tools mentioned in the episode
2 items
Omega-3 Supplementation (EPA)
Supplement
Adjunctive treatment for early-phase psychosis and depression.
Research by colleagues in the field has shown that omega-3 supplementation, specifically at least one gram of EPA per day for 8 to 12 weeks, demonstrated modest but significant benefits for early-phase psychosis and as an adjunctive treatment for depression. However, it did not show the same effect for chronic schizophrenia, highlighting the importance of early intervention and prevention.
um at least one gram including EPA per day. Yeah. Um for I think it was a total of 8 to 12 weeks period. Yeah. Um which significantly uh had a good it was modest uh evidence that showed benefit for uh psychosis uh earlyphase schizophrenia, early phase um psychosis and it's also been a treatment as an adjunctive treatment for depression.
A co-factor that can help improve brain function by supporting mitochondrial pathways.
CoQ10 is mentioned as one of the 'co-factors' or 'helpers' that are involved in the biochemical steps of energy production within mitochondria. The idea is that if a specific metabolic pathway requiring CoQ10 is slow, supplementing with it could speed up that process, leading to improved brain function. This aligns with a personalized approach to addressing mitochondrial dysfunction.
Essentially, co-actors that are involved in these metabolic steps, these biochemical steps require helpers and so they use nutrients like amino acids or CoQ10 or other compounds that actually help improve brain function.
Also said
“Oh, this pathway that requires CoQu 10 is a little slow. So, what if I give extra CoQu 10? It's going to speed it up.”— Illustrates the personalized application of CoQ10 based on specific metabolic needs.
An online platform providing remote care for metabolic psychiatry, aiming to make these treatments accessible nationwide.
DisclosureThe speaker is the founder of Metabolic Psychiatry Labs.
Metabolic Psychiatry Labs is an operational, venture-backed company founded by the speaker to scale up access to metabolic psychiatry care beyond academic centers. It offers remote, digital care, making it accessible across different states. The platform aims to integrate biomarkers, personalization using AI and machine learning, and provide wraparound care, working collaboratively with patients' existing psychiatrists, therapists, or PCPs. This initiative was partly inspired by the speaker's personal experience navigating the healthcare system with a chronic, invisible injury and a desire to create a patient advocacy manual for serious mental illness.
vs alternatives
Contrasts with traditional academic research that often takes decades to translate into clinical practice, and with conventional psychiatry that may not address underlying metabolic issues.
Personal experience
The speaker founded Metabolic Psychiatry Labs out of a desire to make research-backed metabolic interventions accessible to more patients, feeling that research often stays confined to academia. This was also motivated by a personal experience with a significant tailbone injury that was not visibly apparent, leading to a desire to create a 'patient advocacy manual' for those with serious mental illness.
Starting Metabolic Psychiatry Labs is part of that reason.
Also said
“Metabolic Psychiatry Labs is putting together the biomarkers, the personalization using AI, machine learning algorithms to improve the disease states of someone with schizophrenia versus someone with bipolar um and really provide that wraparound care for them and work with their psychiatrist or their therapist or their PCP so uh that they're not alone um in this whole world.”— Details the comprehensive, integrated approach of MPL.
“It's operational. Uh, it is venturebacked and it is um going to grow.”— Confirms the current status and future plans of MPL.
A program at Stanford University that unites nutrition, metabolism, and mental health care, conducting research and offering care for serious mental illnesses.
DisclosureThe speaker is the founding director of Stanford's Metabolic Psychiatry Program.
The Stanford Metabolic Psychiatry Program is where the speaker conducts research and provides care, focusing on metabolism-based interventions for conditions like bipolar disorder, schizophrenia, depression, and eating disorders. This program is actively involved in randomized controlled trials, including one generously funded by philanthropists, to study the mechanistic approaches of interventions like the ketogenic diet and collect extensive 'omics' data. The program aims to put a name to this interdisciplinary field to encourage more clinicians and researchers to work in this area and foster collaborative efforts.
vs alternatives
Contrasts with traditional psychiatric departments that may not integrate nutrition and metabolic health into their core practice.
Personal experience
The speaker established this program at Stanford after years of clinical observation and research, driven by a desire to integrate metabolic insights into psychiatric care and to conduct rigorous scientific studies.
I started the a program at Stanford which is focused on metab metabolism based interventions for uh those with bipolar or schizophrenia or depression and also eating disorders.
Also said
“We really wanted to have at Stanford we wanted to put a name to it so that more uh clinicians and researchers and you know people out there do more work in this area.”— Explains the motivation behind formalizing the program at Stanford.
The Ultra Mind Solution: How to Fix Your Broken Brain by Fixing Your Body First
Book Sponsored · disclosed
A book written by the host that explores the connection between body and brain health, predating much of the current discussion on metabolic psychiatry.
DisclosureAuthored by the host, Dr. Mark Hyman.
The host, Dr. Mark Hyman, mentions his book, 'The Ultra Mind Solution,' which he wrote years ago to highlight the then-unrecognized connection between physical health (e.g., autoimmune disease, insulin resistance, microbiome issues) and psychiatric problems. He observed that when these underlying bodily issues were addressed, psychiatric symptoms often improved or resolved, which was a surprising and repeatable finding in his practice. The book was an attempt to bring this 'body-first' approach to mental health into wider discussion.
vs alternatives
Contrasts with the prevailing medical paradigm that often separates mental and physical health and focuses on symptom management rather than root causes.
Personal experience
The host describes being 'shocked' when treating chronic illnesses and observing that psychiatric problems would resolve. This personal observation and the lack of discussion on the topic motivated him to write the book.
And it's really why I wrote this book, The Ultra Mind Solution: How to Fix Your Broken Brain by Fixing Your Body First. because I was like, "Wait a minute, nobody's talking about this."
A platform that provides access to comprehensive biomarker testing, including advanced metabolic and nutritional markers.
DisclosureThe host, Dr. Mark Hyman, is involved with Function Health.
Function Health is highlighted as a platform that improves access to detailed lab testing, which is crucial for the personalized approach of metabolic psychiatry. It offers a wide range of biomarkers, including insulin resistance scores, triglyceride/HDL ratio, particle size, inflammation markers (CRP), and nutrient levels (e.g., vitamin D, homocysteine, omega-3 index). The platform has collected a massive dataset from its members, revealing high rates of nutritional deficiencies and metabolic dysfunction in the general population. This data is being used to learn about population health and potentially collaborate on research projects, such as with Stanford, to accelerate understanding and treatment of mental illness.
vs alternatives
Offers more comprehensive and advanced biomarker testing than typically available through standard clinical labs, which often miss subtle but significant dysfunctions.
Personal experience
The host's involvement with Function Health allows him to observe population-level data, which reinforces the widespread nature of metabolic and nutritional issues impacting health.
I love that Function Health um has been able to really improve the access to get these labs.
Also said
“Here we have almost 300,000 members and hundreds and biomarkers on each one which is tens of millions of biomarkers.”— Highlights the scale and data richness of Function Health.
“We're seeing like 70% have a nutritional deficiency at the minimum level that's actually recommended by the dietary.”— Provides a specific statistic on the prevalence of deficiencies observed through Function Health data.
Lines worth pulling out — contrarian, specific, or perfectly phrased
6 items
The joke in medicine is neurologists pay no attention to the mind and psychiatrists pay no attention to the brain and also I would say psychiatrists pay no attention to the body in terms of what's happening that could be influencing the brain.
This quote humorously but pointedly critiques the historical siloing of medical specialties, particularly in psychiatry's neglect of the body-brain connection.
If your brain is inflamed, what happens? It doesn't hurt. They don't get a headache, it creates mental illness.
This is a powerful and concise explanation of why brain inflammation is often overlooked as a cause of mental illness, as its symptoms are not physical pain but psychiatric.
The greatest discoveries are discovered in between in this intersection between fields and sometimes I think we forget that the body is related and you know organs um are not just isolated and they're working in a whole system.
This quote from Stanford's medical school dean emphasizes the importance of interdisciplinary approaches, which is central to metabolic psychiatry's philosophy.
You can treat the symptom or you can treat the cause. And I think the metabolic psychiatry approach, you know, like you said, has many tools like metformin is a drug that helps improve it.
This succinctly captures the core difference between conventional and metabolic psychiatry: the shift from symptom management to root cause resolution.
It's almost like a crime to not to not uh be thinking about it. And I that's why I think it's really important um to have that approach.
This expresses a strong conviction about the ethical imperative to consider nutritional status and metabolic health in psychiatric care.
This is this this sort of weird moment in psychiatry where I think we're kind of converging these two massive paradigm shifts. one is around psychedelic medicine, trauma, and and then metabolic psychiatry at the same time. And it feels like they're complimentary.
This highlights a unique and exciting convergence of two major, previously disparate, paradigm shifts in psychiatry, suggesting a more comprehensive future for mental health treatment.
Sign in to share feedback
Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.
Topics covered
metabolic psychiatry definitionbody-mind connectionhistorical context of psychiatrymetabolic pathwaysinsulin resistancecerebral glucose hypometabolismpsychiatric medications side effectsneuronal plasticitymitochondrial dysfunctioninflammationoxidative stressmetforminneurotransmitterslifestyle and dietexercise and mental healthbrain-derived neurotrophic factor (bdnf)mitochondrial therapiesnutrient deficienciesomega-3 supplementationbiomarkers of mental illness
Free account
Make this library yours
Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.
Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.
